GB9412711D0 - Medical use of bromelain - Google Patents

Medical use of bromelain

Info

Publication number
GB9412711D0
GB9412711D0 GB9412711A GB9412711A GB9412711D0 GB 9412711 D0 GB9412711 D0 GB 9412711D0 GB 9412711 A GB9412711 A GB 9412711A GB 9412711 A GB9412711 A GB 9412711A GB 9412711 D0 GB9412711 D0 GB 9412711D0
Authority
GB
United Kingdom
Prior art keywords
bromelain
medical use
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9412711A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortecs Ltd
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Priority to GB9412711A priority Critical patent/GB9412711D0/en
Publication of GB9412711D0 publication Critical patent/GB9412711D0/en
Priority to IL11433195A priority patent/IL114331A0/en
Priority to EP95922672A priority patent/EP0766565A1/en
Priority to PCT/GB1995/001501 priority patent/WO1996000082A1/en
Priority to CA002193654A priority patent/CA2193654A1/en
Priority to AU27493/95A priority patent/AU2749395A/en
Priority to CN95193767A priority patent/CN1151119A/en
Priority to KR1019960707424A priority patent/KR970703784A/en
Priority to ZA955292A priority patent/ZA955292B/en
Priority to JP8502932A priority patent/JPH10502073A/en
Priority to TW084106855A priority patent/TW403654B/en
Priority to FI965204A priority patent/FI965204A/en
Priority to NO965564A priority patent/NO965564L/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB9412711A 1994-06-24 1994-06-24 Medical use of bromelain Pending GB9412711D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GB9412711A GB9412711D0 (en) 1994-06-24 1994-06-24 Medical use of bromelain
IL11433195A IL114331A0 (en) 1994-06-24 1995-06-25 Medical use of bromelain
JP8502932A JPH10502073A (en) 1994-06-24 1995-06-26 Use of bromelain in medicine
CN95193767A CN1151119A (en) 1994-06-24 1995-06-26 Medical use of bromelain
PCT/GB1995/001501 WO1996000082A1 (en) 1994-06-24 1995-06-26 Medical use of bromelain
CA002193654A CA2193654A1 (en) 1994-06-24 1995-06-26 Medical use of bromelain
AU27493/95A AU2749395A (en) 1994-06-24 1995-06-26 Medical use of bromelain
EP95922672A EP0766565A1 (en) 1994-06-24 1995-06-26 Medical use of bromelain
KR1019960707424A KR970703784A (en) 1994-06-24 1995-06-26 Medicinal uses of bromelain
ZA955292A ZA955292B (en) 1994-06-24 1995-06-26 Medical use of bromelain
TW084106855A TW403654B (en) 1994-06-24 1995-07-04 Medical use of bromelain
FI965204A FI965204A (en) 1994-06-24 1996-12-23 Medical use of bromelain
NO965564A NO965564L (en) 1994-06-24 1996-12-23 Medical application of bromelain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9412711A GB9412711D0 (en) 1994-06-24 1994-06-24 Medical use of bromelain

Publications (1)

Publication Number Publication Date
GB9412711D0 true GB9412711D0 (en) 1994-08-17

Family

ID=10757263

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9412711A Pending GB9412711D0 (en) 1994-06-24 1994-06-24 Medical use of bromelain

Country Status (13)

Country Link
EP (1) EP0766565A1 (en)
JP (1) JPH10502073A (en)
KR (1) KR970703784A (en)
CN (1) CN1151119A (en)
AU (1) AU2749395A (en)
CA (1) CA2193654A1 (en)
FI (1) FI965204A (en)
GB (1) GB9412711D0 (en)
IL (1) IL114331A0 (en)
NO (1) NO965564L (en)
TW (1) TW403654B (en)
WO (1) WO1996000082A1 (en)
ZA (1) ZA955292B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9526691D0 (en) * 1995-12-29 1996-02-28 Cortecs Ltd Medical use of proteases
US20020102253A1 (en) 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
CN1204258C (en) * 1997-02-25 2005-06-01 科特克斯(英国)有限公司 Component of bromelain
AU6303898A (en) 1997-02-25 1998-09-18 Cortecs (Uk) Limited Component of bromelain
NO304766B1 (en) 1997-06-16 1999-02-08 Sintef fingerprint Sensor
DE19726255C2 (en) * 1997-06-20 2000-03-16 Mucos Pharma Gmbh & Co Influence of cytokines by proteolytic enzymes and rutoside
DE19726248C2 (en) * 1997-06-20 2000-03-02 Mucos Pharma Gmbh & Co Use of proteolytic enzymes and rutoside to treat septic shock
DE19726244C2 (en) * 1997-06-20 2000-03-02 Mucos Pharma Gmbh & Co Use of proteolytic enzymes and rutoside to prevent or treat graft rejection
DE19726254C2 (en) * 1997-06-20 1999-10-21 Mucos Pharma Gmbh & Co Tolerance induction through proteases
GB9713667D0 (en) * 1997-06-27 1997-09-03 Cortecs Ltd Enhancement of intestinal permeability
GB9819138D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Nucleic acids and proteins from pineapple stem
GB9819137D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Component of bromelain
DE19847114A1 (en) * 1998-10-13 2000-04-20 Mucos Pharma Gmbh & Co Use of proteolytic enzymes to modulate hyperactive T cells, especially for symptomatic treatment of immune-mediated inflammatory diseases, e.g. multiple sclerosis, diabetes, arthritis or glomerulonephritis
JP2002532415A (en) * 1998-12-16 2002-10-02 ワーナー−ランバート・カンパニー Treatment of arthritis with MEK inhibitors
DE19957318A1 (en) * 1999-11-29 2001-06-21 Mucos Pharma Gmbh & Co Influence of TGF-beta by proteolytic enzymes
DE10018980A1 (en) * 2000-04-17 2001-11-08 Mucos Pharma Gmbh & Co Prophylaxis and therapy of diabetes mellitus I using proteolytic enzymes
EP1208849B1 (en) * 2000-11-28 2015-10-28 URSAPHARM Arzneimittel GmbH Use of bromelain for adjuvant therapy during wound healing process
TW201419131A (en) 2012-11-09 2014-05-16 Health & Life Co Ltd Voice-assisted biomedical sensing apparatus
US9526768B2 (en) * 2014-11-13 2016-12-27 Jennifer Mai Compositions for the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59225122A (en) * 1983-05-23 1984-12-18 Kaken Pharmaceut Co Ltd Remedy and improver for cancerous cachexia
ATE119780T1 (en) * 1989-10-06 1995-04-15 Mucos Emulsions Gmbh CATABOLIC ENZYMES FOR INDUCTION OF TUMOR NECROSIS FACTOR (TNF).
DE4302060A1 (en) * 1993-01-26 1994-07-28 Mucos Pharma Gmbh & Co Use of bromelain as CD44 surface molecule modifier
GB9313188D0 (en) * 1993-06-25 1993-08-11 Cortecs Ltd Medical use of enzymes

Also Published As

Publication number Publication date
JPH10502073A (en) 1998-02-24
TW403654B (en) 2000-09-01
WO1996000082A1 (en) 1996-01-04
NO965564L (en) 1997-02-24
FI965204A0 (en) 1996-12-23
ZA955292B (en) 1997-07-28
EP0766565A1 (en) 1997-04-09
AU2749395A (en) 1996-01-19
NO965564D0 (en) 1996-12-23
FI965204A (en) 1997-02-21
IL114331A0 (en) 1995-10-31
CN1151119A (en) 1997-06-04
KR970703784A (en) 1997-08-09
CA2193654A1 (en) 1996-01-04

Similar Documents

Publication Publication Date Title
IL114331A0 (en) Medical use of bromelain
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
HU9700071D0 (en) Use of muramilpeptides
GB9414157D0 (en) Medical use
GB9313188D0 (en) Medical use of enzymes
IL113992A0 (en) Use of copolymer-1
HUP9800146A3 (en) Thalidomide-derivatives and use of them
GB9403344D0 (en) Medical application of bromelain
HUP9901448A3 (en) Novel medical use
GB9526691D0 (en) Medical use of proteases
GB9412983D0 (en) Novel types of medical use for amphotericin b
GB9408084D0 (en) Medical treatment
EP0941105A4 (en) Pretraumatic use of hemoglobin
PL319344A1 (en) Gene of human galactokinase
GB9308164D0 (en) Medical use of enzymes
GB9313189D0 (en) Medical use of enzymes
ZA934714B (en) Medical use of enzymes
ZA951440B (en) Novel opiold peptides for the treatment of pain and use thereof
GB9725478D0 (en) Treatment of cotton
GB9726745D0 (en) Treatment of medical conditions
GB9425164D0 (en) Medical treatment
GB9421398D0 (en) Medical treatment
GB9425773D0 (en) Medical treatment
GB9424728D0 (en) Medical treatment
ZA951421B (en) Medical treatment